Haihua Gu

Haihua Gu is the Senior Director at JW Therapeutics, focusing on pre-clinical discovery and research on CAR T projects and platforms. Prior to this, Haihua has held various roles in companies such as WuXi Biologics, Sorrento Therapeutics, Inc., and HD Biosciences Co., Ltd., where Haihua conducted research in immunology therapy, cell therapy, and oncology. With a strong background in PK, PK/PD, and in vivo studies, Haihua has contributed significantly to the development of new cell therapy manufacturing processes and cost-saving methods. Their expertise in gene editing, cellular assays, and in vivo skills make their a valuable asset in the field of immunology and oncology research.